← Back to Clinical Trials
Recruiting NCT05855421

NCT05855421 Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05855421
Status Recruiting
Phase
Sponsor Universidade do Sul de Santa Catarina
Condition Depressive Symptoms
Study Type INTERVENTIONAL
Enrollment 280 participants
Start Date 2023-03-01
Primary Completion 2025-12-15

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
Auricular Acupuncture

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 280 participants in total. It began in 2023-03-01 with a primary completion date of 2025-12-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.

Eligibility Criteria

Inclusion Criteria: * Age between 18 and 50 years old * PHQ-9 score between 10 and 19 (moderate depression) * Availability for sessions Exclusion Criteria: Use complementary and integrative practices at the last 3 months; Suicidal risk evaluated by question number 9 in the PHQ-9 Severe depression score in the PHQ-9 Prior use of auricular acupuncture Pregnancy Menopause Tape and metal allergy

Contact & Investigator

Central Contact

Daniel MO Rodrigues, MSc

✉ danielmor7@gmail.com

📞 5548 8825-1444

Frequently Asked Questions

Who can join the NCT05855421 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 50 Years, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05855421 currently recruiting?

Yes, NCT05855421 is actively recruiting participants. Contact the research team at danielmor7@gmail.com for enrollment information.

Where is the NCT05855421 trial being conducted?

This trial is being conducted at Palhoça, Brazil.

Who is sponsoring the NCT05855421 clinical trial?

NCT05855421 is sponsored by Universidade do Sul de Santa Catarina. The trial plans to enroll 280 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology